Skip to main content

CareTrust REIT, Inc.

corporate_fare Company Profile

CareTrust REIT, Inc.

CTRE·NYSE·Real Estate & Construction·CIK 0001590717

CareTrust REIT is a self-administered, publicly-traded real estate investment trust (REIT) that owns, acquires, finances, develops, and leases skilled nursing, senior housing, and other healthcare-related properties. As of December 31, 2025, CareTrust REIT owned and leased to independent operators 407 skilled nursing facilities, senior housing communities, and other properties, directly or indirectly in consolidated joint ventures. These properties consist of 37,628 operational beds and units located in 32 states and the United Kingdom, with the highest concentration of properties by rental income in California, the U.K., Texas, and Tennessee. As of December 31, 2025, the company also held other real estate related investments, including four preferred equity investments, 16 real estate secured loans receivable with a carrying value of $899.3 million, and five mezzanine loans receivable with a carrying value of $899.3 million, along with one financing receivable with a carrying value of $92.2 million. During the fourth quarter of 2025, CareTrust REIT began using the REIT Investment Diversification and Empowerment Act of 2007 (RIDEA) structure to establish a senior housing operating portfolio (SHOP) platform, completing its first SHOP acquisition in December 2025. As of December 31, 2025, CareTrust REIT also indirectly owned, in consolidated joint ventures, the properties and operations of three senior housing communities with 270 units in Texas, managed by independent managers. The company primarily generates revenue by leasing healthcare-related properties to healthcare operators through triple-net lease arrangements, where the tenant is responsible for property costs (including property taxes, insurance, maintenance, repair, and capital expenditures, with some exceptions for properties leased to Ensign and Pennant). CareTrust REIT also extends secured mortgage loans and secured mezzanine loans to healthcare operators and invests in preferred equity investments.

CareTrust REIT, Inc. (NYSE:CTRE) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 26 items for CTRE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for CTRE spans 8-K, 10-Q, 424B5.

Recent high-impact activity:

  • CareTrust Finalizes 19.55M-Share Forward Offering at $37.50, $36.00 Forward Price
  • CareTrust Prices 17M-Share Forward Offering at $37.50, Raising ~$637.5M
  • CareTrust Launches 17 Million-Share Stock Offering to Fund Growth
  • CareTrust REIT Posts $83.7M Third-Quarter Net Income
  • CareTrust Q3 Normalized FFO Up 20%, Raises 2026 Guidance Midpoints

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$476.39M
Net Income
$320.54M
Diluted EPS
$1.57
Op. Cash Flow
$394.03M
Cash & Equivalents
$198.04M
Total Debt
$894.22M
Debt / Equity
0.22×
Net Margin
67.3%
Shares Outstanding
222.75M sh
Source: 10-K · filed 2026-02-12 · accession 0001628280-26-007664

Short Interest & Short Volume

4.09 days to cover

FINRA reported short interest of 9,471,841 shares in CTRE as of the October 30, 2026 settlement, a 5.5% decrease from the prior period — about 4.1 days to cover at its recent average daily volume. On November 20, 2026, 13.9% of CTRE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,471,841 shares as of October 30, 2026
Change vs prior period▼ 5.5%
Days to cover4.09 at avg daily volume of 2,313,512
Daily short volume (FINRA facilities)13.9% of 1,360,465 shares on November 20, 2026
5-day average short volume21.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for CTRE, detected from its recent SEC filings · based on capital-structure filings through 2026-11-13.

1 recent capital raise

Final Prospectus for Priced Forward Offering · Expected Proceeds and Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$37.22 +1.28% today
52-week range · as of 2026-11-13 $34.74 – $43.62
Market cap
$9.47B
Volume
3.2M (1.0× avg)
3-mo avg 3.2M
Live data · 2026-11-21 22:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CTRE - Latest Insights

CTRE
Nov 13, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.07
Real-time Price: $37.22 info
Change: -$0.850 (-2%) info
Market Cap: $9.469B info
CTRE
Nov 12, 2026, 12:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $37.52
Real-time Price: $37.22 info
Change: -$0.2995 (-0.80%) info
Market Cap: $9.469B info
CTRE
Nov 11, 2026, 4:37 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.04
Real-time Price: $37.22 info
Change: -$1.82 (-5%) info
Market Cap: $9.469B info
CTRE
Nov 05, 2026, 4:12 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.22 info
Change: +$0.040 (+0.11%) info
Market Cap: $9.469B info
CTRE
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.22 info
Change: +$0.040 (+0.11%) info
Market Cap: $9.469B info
CTRE
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $37.22 info
Change: +$0.040 (+0.11%) info
Market Cap: $9.469B info
CTRE
Oct 29, 2026, 9:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.52
Real-time Price: $37.22 info
Change: +$0.700 (+2%) info
Market Cap: $9.469B info
CTRE
Oct 02, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $36.29
Real-time Price: $37.22 info
Change: +$0.930 (+3%) info
Market Cap: $9.469B info
CTRE
Oct 02, 2026, 4:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $36.70
Real-time Price: $37.22 info
Change: +$0.520 (+1%) info
Market Cap: $9.469B info
CTRE
Sep 15, 2026, 6:30 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $38.11
Real-time Price: $37.22 info
Change: -$0.890 (-2%) info
Market Cap: $9.469B info
CTRE
Aug 06, 2026, 4:20 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $41.13
Real-time Price: $37.22 info
Change: -$3.91 (-10%) info
Market Cap: $9.469B info
CTRE
Aug 06, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $41.13
Real-time Price: $37.22 info
Change: -$3.91 (-10%) info
Market Cap: $9.469B info
CTRE
May 21, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $41.01
Real-time Price: $37.22 info
Change: -$3.79 (-9%) info
Market Cap: $9.469B info
CTRE
May 21, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $41.01
Real-time Price: $37.22 info
Change: -$3.79 (-9%) info
Market Cap: $9.469B info
CTRE
May 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.49
Real-time Price: $37.22 info
Change: -$4.27 (-10%) info
Market Cap: $9.469B info
CTRE
May 20, 2026, 6:05 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $41.50
Real-time Price: $37.22 info
Change: -$4.28 (-10%) info
Market Cap: $9.469B info
CTRE
May 18, 2026, 11:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $41.00
Real-time Price: $37.22 info
Change: -$3.78 (-9%) info
Market Cap: $9.469B info
CTRE
May 18, 2026, 4:17 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $41.25
Real-time Price: $37.22 info
Change: -$4.03 (-10%) info
Market Cap: $9.469B info
CTRE
May 07, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $38.99
Real-time Price: $37.22 info
Change: -$1.77 (-5%) info
Market Cap: $9.469B info
CTRE
May 07, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $38.99
Real-time Price: $37.22 info
Change: -$1.77 (-5%) info
Market Cap: $9.469B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets